Several major studies reported average body-weight reductions approaching 25-30%, placing Retatrutide among the most promising metabolic peptides currently under investigation
These glycemic improvements occur without a corresponding increase in severe hypoglycemia when used as monotherapy, though the risk of hypoglycemia increases when semaglutide is combined with insulin or sulfonylureas
From there, it can enter the bloodstream, where it seems to function as a signal conveying information about the energetic state of the cell to other tissues
However, these approaches produce much smaller metabolic effects compared to prescription semaglutide and should not be considered direct substitutes when medication is clinically indicated
It helps your body stay strong so progress does not come at the expense of muscle
Below is a clear, easy-to-read breakdown of the benefits, the mechanisms behind them, and how an approach like the one at PRIME Medicine supports long-term metabolic health